Related references
Note: Only part of the references are listed.
Review
Gastroenterology & Hepatology
Gretchen A. Lam et al.
Summary: Periodontal disease can lead to chronic inflammation and subsequent development of inflammatory gastrointestinal disorders. Dysbiosis of oral microbiota may alter the gut microbiome and contribute to digestive carcinogenesis. Understanding the oral-gut microbial link and using mouse models can provide insights for diagnosis and future treatment.
INFLAMMATORY BOWEL DISEASES
(2023)
Review
Gastroenterology & Hepatology
Harris A. Ahmad et al.
Summary: Inflammatory bowel disease, including Crohn's disease and ulcerative colitis, is a condition characterized by uncontrolled inflammation in the gastrointestinal tract. Artificial intelligence is increasingly being used to provide accurate evaluations of endoscopic appearance and histologic activity in patients with inflammatory bowel disease. These AI tools also have the potential to predict treatment response to biologic therapies and improve the standard of care, by personalizing treatment options and reducing costs.
INTESTINAL RESEARCH
(2023)
Review
Gastroenterology & Hepatology
Ying Qi et al.
Summary: Inflammatory bowel disease (IBD) is a group of chronic intestinal inflammatory disorders characterized by genetic susceptibility, environmental triggers, and immune system disruption. Dysbiosis of the gut and oral microbiota may exacerbate IBD progression. Ectopic colonization of specific oral bacteria in the gut could lead to chronic intestinal inflammation in IBD patients.
DIGESTIVE DISEASES AND SCIENCES
(2022)
Article
Genetics & Heredity
Ryszard Kubinski et al.
Summary: In order to reduce the time it takes to diagnose inflammatory bowel disease (IBD) and improve patient well-being, researchers are exploring machine learning algorithms that can diagnose IBD based on the composition of the gut microbiome. However, current models have limited clinical application due to decreased performance when applied to new patient samples. Therefore, it is important to evaluate different machine learning pipelines and generate curated training datasets to improve the generalizability of microbiome-based IBD diagnostic tools.
FRONTIERS IN GENETICS
(2022)
Review
Gastroenterology & Hepatology
Nurulamin M. Noor et al.
Summary: Clinical management of IBD has relied on trial and error, but precision medicine approaches are now available to guide treatment decisions. Early action combined with precision tools offers the greatest opportunity to improve outcomes for individual IBD patients. Despite the lack of clinical impact to date, there is potential for promising breakthroughs in precision medicine for IBD.
INFLAMMATORY BOWEL DISEASES
(2022)
Article
Multidisciplinary Sciences
Wenxuan Zuo et al.
Summary: Using both 16S rRNA and metagenomic shotgun sequencing, we found that pediatric UC is associated with lower alpha diversity, higher beta diversity, and specific changes in microbial families and species compared to healthy children. We also demonstrated that 16S rRNA data can accurately predict pediatric UC, similar to shotgun data, but with lower cost and labor. These findings were confirmed in an independent dataset.
SCIENTIFIC REPORTS
(2022)
Article
Microbiology
Jose Linares-Blanco et al.
Summary: This study generated a metagenomic signature with predictive capacity to identify inflammatory bowel disease (IBD) from fecal samples. Different machine learning models were trained and the identified signature showed high performance in both subtypes of IBD. The study also identified different genera that play an important and common role in the development of these two subtypes.
FRONTIERS IN MICROBIOLOGY
(2022)
Review
Gastroenterology & Hepatology
Soo-Young Na et al.
Summary: Patients with IBD are at higher risk of developing CRC, and surveillance colonoscopy should be tailored to individualized risk factors. Chromoendoscopy and high-definition colonoscopy are recommended choices for surveillance techniques.
CLINICAL ENDOSCOPY
(2022)
Article
Microbiology
Seung Yong Shin et al.
Summary: This study revealed common and unique microbiome patterns in saliva, intestinal tissue biopsy, and stool samples from patients with Crohn's disease. The microbial community in saliva was significantly different from that in tissue and stool. Prevotella and Streptococcus were common genera in saliva, tissue, and stool microbiomes.
Article
Immunology
Mohamed M. H. Abdelbary et al.
Summary: Inflammatory bowel disease (IBD) patients showed significant alterations in the microbial composition of saliva, with higher abundance of Veillonella and Prevotella compared to healthy controls, while Neisseria, Streptococcus, Haemophilus, and Fusobacterium were associated with a healthy gut state. Additionally, the IBD group had higher abundance of pathogenic bacteria such as Clostridium sensu stricto 1 and Escherichia-Shigella in fecal microbiome compared to control group.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
(2022)
Article
Biotechnology & Applied Microbiology
Siyuan Ma et al.
Summary: Microbiome studies have developed a method for normalization, statistical meta-analysis, and population structure discovery. By applying this method to IBD cohorts, consistent associations and novel taxa have been identified. Additionally, a framework for summarizing population structure has been proposed.
Article
Biochemistry & Molecular Biology
Natalia Molinero et al.
Summary: This study compared the differences in the oral microbiome between UC patients and healthy individuals. It found that UC patients have a decrease in alpha diversity and an imbalance in the relative proportions of some key members of the oral core microbiome. Additionally, specific Staphylococcus members and differential species were only present in UC patients.
CURRENT ISSUES IN MOLECULAR BIOLOGY
(2022)
Review
Pediatrics
Khalid Elmaghrawy et al.
Summary: The oral microbiome may play an important role in the development of gastrointestinal diseases, including Crohn's disease and ulcerative colitis. Bacteria and yeasts from the oral cavity may translocate to the gut, triggering inflammation, and dysbiosis of the oral microbiome could potentially serve as a biomarker for GI health.
FRONTIERS IN PEDIATRICS
(2021)
Article
Gastroenterology & Hepatology
Hari K. Somineni et al.
Summary: The study reveals significant dysbiosis in the oral microbiome of patients with inflammatory bowel disease (IBD), with different sites and bacterial groups affected to varying degrees. Salivary microbiota shows the best performance in distinguishing IBD patients from healthy controls, with some taxa consistently perturbed and site-dependent changes observed over time.
INFLAMMATORY BOWEL DISEASES
(2021)
Article
Medicine, General & Internal
Soo-Kyung Park et al.
Summary: This study developed a machine learning model using RNA sequencing data to differentiate Crohn's disease and ulcerative colitis. By mapping to the human reference genome and quantifying genes in biopsy tissue, the model could effectively distinguish between the two diseases.
Review
Gastroenterology & Hepatology
John Gubatan et al.
Summary: Inflammatory bowel disease (IBD) is a complex gastrointestinal disorder with increasing global incidence and significant morbidity. Recent advances in artificial intelligence and machine learning technologies have shown promising results in the diagnosis, risk prediction, and assessment of disease severity in IBD patients.
WORLD JOURNAL OF GASTROENTEROLOGY
(2021)
Article
Multidisciplinary Sciences
Gregory C. A. Amos et al.
Summary: This study investigated the relationship between inflammatory bowel disease (IBD) and the microbiome, revealing significant differences in microbiome signatures across different IBD conditions and disease locations. Changes in taxonomic composition led to functional dysbioses, particularly in Short-Chain Fatty Acid (SCFA) pathways in patients with Crohn's disease (CD). Consistent strategies for clinical cohort stratification and downstream analysis are needed to ensure comparability across microbiome studies and clinical trials.
SCIENTIFIC REPORTS
(2021)
Article
Rheumatology
Jian Yin et al.
ANNALS OF THE RHEUMATIC DISEASES
(2020)
Review
Biotechnology & Applied Microbiology
Huang Lin et al.
NPJ BIOFILMS AND MICROBIOMES
(2020)
Review
Pediatrics
Bobak Moazzami et al.
TURKISH JOURNAL OF PEDIATRICS
(2019)
Review
Multidisciplinary Sciences
Travers Ching et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE
(2018)
Article
Microbiology
Zhe Xun et al.
FRONTIERS IN MICROBIOLOGY
(2018)
Review
Gastroenterology & Hepatology
Josephine Ni et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY
(2017)
Article
Gastroenterology & Hepatology
Michael J. Docktor et al.
INFLAMMATORY BOWEL DISEASES
(2012)
Article
Biochemical Research Methods
Kim-Anh Le Cao et al.
BMC BIOINFORMATICS
(2011)
Review
Multidisciplinary Sciences
Bernard Khor et al.
Review
Biotechnology & Applied Microbiology
JR Korzenik et al.
NATURE REVIEWS DRUG DISCOVERY
(2006)
Review
Medicine, General & Internal
DK Podolsky
NEW ENGLAND JOURNAL OF MEDICINE
(2002)
Review
Gastroenterology & Hepatology
EV Loftus et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA
(2002)
